Patient safety, news and press releases from EMA
- Call for expressions of interest for civil society representatives to participate in work of EMA , PRAC, 22/09/2021
- Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 August – 2 September 2021, PRAC, 03/09/2021
- Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 13-16 September 2021, CHMP, 17/09/2021
- New add-on treatment for rare autoimmune inflammatory disorder, CHMP, 17/09/2021
- Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 7-9 September 2021, CVMP, 10/09/2021
- Increase in manufacturing capacity for COVID-19 vaccine from BioNTech/Pfizer, CHMP, 09/09/2021
- ECDC and EMA highlight considerations for additional and booster doses of COVID-19 vaccines, , 02/09/2021
- Increase in vaccine manufacturing capacity for COVID-19 vaccines from BioNTech / Pfizer and Moderna, CHMP, 24/08/2021
MedWatch Safety Alert RSS Feed
- Medtronic Recalls Pipeline Flex Embolization Devices for Risk of Delivery System Fractures During Placement, Retrieval, or Movement of Device
- IntegraDose Compounding Services, LLC Issues Voluntary Nationwide Recall of Cefazolin Injection Products Due to a Lack of Sterility Assurance
- 2021 Medical Device Recalls
- Potential for False Positive Results with Abbott Molecular Inc. Alinity m SARS-CoV-2 AMP and Alinity m Resp-4-Plex AMP Kits - Letter to Clinical Laboratory Staff and Health Care Providers
- Pfizer Expands Voluntary Nationwide Recall to include All Lots of CHANTIX® (Varenicline) Tablets Due to N-Nitroso Varenicline Content
- Smiths Medical Recalls NORMOFLO Irrigation Fluid Warmers and Warming Sets Due to the Possibility of Harmful Levels of Aluminum Leaching into the Fluid Path of the Warmers
- Urgent Voluntary Recall: Level 1 Fast Flow Fluid Warming System, NORMOFLO Fluid Warmer and Level 1 Normothermic I.V. Fluid Administration Set
- 2021 Biologics Recalls
- Potential Risk of Aluminum Leaching with Use of Certain Fluid Warmer Devices - Letter to Health Care Providers
- Jacobus Pharmaceutical Company Inc. Issues Voluntary Worldwide Recall of Ruzurgi® (amifampridine) 10 mg Tablets Due to Yeast, Mold, and Bacterial Contamination